Seeking Alpha

Regeneron Pharms (REGN): Q2 EPS of $0.90 beats by $0.45. Revenue of $304M (+181.5% Y/Y) beats by...

Regeneron Pharms (REGN): Q2 EPS of $0.90 beats by $0.45. Revenue of $304M (+181.5% Y/Y) beats by $48.02M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector